CliffBio
small molecule

CYKLX

ARTICAINE HYDROCHLORIDE

Loss of exclusivityMarch 2039latest FDA-listed patent expiry
CompanyThea →View the full company profile on CliffBio

Drug detail

Brand nameCYKLX
Active ingredientARTICAINE HYDROCHLORIDE
StrengthEQ 8% BASE
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalAugust 2025
Marketing statusDISCN

Listed patents

PatentExpiresType
12403126March 2039product
11826347March 2039product
11096922March 2039product

Regulatory exclusivity

CodeExpires
NPAugust 2028

More from Thea

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

CYKLX patent cliff — loss of exclusivity March 2039 | CliffBio